A prototype of a visually-guided hearing aid (VGHA) designed at Boston University of a the formed beam is manipulated by eye gaze to improve the ability of users of the technology to better focus on one sound despite the presence of nearby competing sounds.
A look at the current and future landscape of treatment options for this age-related condition.
Researchers are attempting to determine how pediatric visual impairment caused by damage to the brain is different from visual impairment at the level of the eye.
Researchers found that patients with nAMD lost vision as a result of the lockdown and reduced number of treatments during the COVID-19 pandemic.
At-home visual acuity tests compare favorably within 1 line of vision to VA measurements performed during a standard office visit.
Vascular density might be a biomarker for microvascular abnormalities following COVID-19
Acute infection did not impact the ability to obtain reliable test results
Researchers report a recombinant biologic derived from blood-feeding ticks may be a potential treatment for allergic eye disease
The National Institute for Health and Care Excellences announced SLT as the new primary form of glaucoma intervention.
Pipeline treatments for presbyopia, myopia, and demodex are expanding rapidly
Lee Peplinski, OD, FAAO, emphasizes the importance of interventional care in patients with glaucoma.
Clinical pearls on amblyopia, thyroid eye disease, and papilledema treatments from SECO 2022.
Clinical pearls on giant cell arteritis (GCA) and optic neuritis
Tools and therapies for dry eye with contact lens wear
Other factors, besides IOP, can contribute to glaucomatous optic nerve damage
Optometrists at the forefront of ocular basal cell and squamous cell carcinomas
OCT showed inner retinal hyperreflectivity, diffuse retinal thickening with intraretinal fluid, and a serous macular detachment.
SARS-CoV-2 may target lacrimal gland tissue and manifest as chronic inflammation
Latest innovations within the presbyopic landscape are proving game-changers for better patient treatment.
Sustained-release injectables may be key to addressing the greatest obstacles in glaucoma.
Risk factors take priority
The future is sustained-release injectables
Industry keenly focused on innovations
Israeli researchers find a second booster shot was especially effective in individuals over 60 years of age, and “made them three times more resistant to serious illness."
Canadian researchers have found that rapid antigen tests to detect the SARS-CoV-2 virus are associated with a very low rate of false positive results.
Diagnosing COVID-19 just got faster with a test that claims to provide rapid virus detection markedly faster than reverse-transcriptase polymerase chain reaction (RT-PCR) testing.
Investigators report that maintenance hemodialysis does not seem to impact the effectiveness of vaccines against the COVID-19 virus in most study patients.
